RecruitingNot ApplicableNCT05175885

Ex Vivo Normothermic Perfusion in Kidney Transplantation.

Multicenter, Prospective and Open-label Clinical Trial to Evaluate the Viability, Performance and Safety of ex Vivo Normothermic Perfusion in Kidney Transplantation From DCD and DBD Donors.

Sponsor

Ebers Medical Technology, S.L.

Enrollment

100 participants

Start Date

Dec 14, 2023

Study Type

INTERVENTIONAL

Conditions

Kidney Transplantation

Summary

A multicenter, prospective and open-label clinical investigation to evaluate the viability, performance and safety of ex vivo normothermic perfusion in kidney transplantation from DCD and DBD donors.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cold preservation and a medical device called Ex vivo normothermic perfusion for people with kidney transplantation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEx vivo normothermic perfusion

Ex vivo normothermic perfusion (EVNP) of the renal graft with the Ark Kidney System

DEVICECold preservation

Static cold storage (SCS) or hypothermic machine perfusion (HMP) of the renal graft

Locations(1)

Miguel Servet University Hospital

Zaragoza, Zaragoza, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05175885

Related Trials

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

NCT072247631 location

Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing

NCT062105552 locations

Continuous Glucose Monitoring (CGM) After Kidney Transplantation

NCT066759031 location

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

NCT0674464755 locations

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

NCT068244541 location